OMI Welcomes Christopher Windham as New COO and Chief Clinical Officer
OMI Welcomes Christopher Windham as New COO and Chief Clinical Officer
Outcomes Matter Innovations, commonly referred to as OMI, has announced a significant addition to its leadership team: Dr. Christopher Windham, MD, has been appointed as the Executive Chief Operating Officer (COO) and Chief Clinical Officer (CCO). This strategic move is part of OMI's ongoing dedication to enhancing its high-value specialty care platform, allowing the company to better serve its partnerships within the healthcare landscape.
Who is Dr. Christopher Windham?
Dr. Windham is not a newcomer to the healthcare industry. He comes with substantial credentials, including a surgical oncologist background, having completed rigorous research and clinical fellowships at prestigious institutions such as MD Anderson Cancer Center and Moffitt Cancer Center. Along with his extensive medical training, he holds a Master of Healthcare Management from Harvard University and a Master of Population Health Management from Johns Hopkins University.
His professional journey includes prominent executive leadership roles at organizations like Lumeris and Cone Health, where he focused on transformation in the healthcare delivery system and fostering physician engagement. Dr. Windham's wealth of experience in operational execution in multifaceted healthcare environments positions him as a valuable asset to OMI.
Responsibilities at OMI
In his new role, Dr. Windham will take on the important task of overseeing clinical and operational execution at OMI. His responsibilities involve scaling the company’s high-value specialty care model, which is designed to integrate seamlessly into both provider and payer partnerships. His extensive network within the healthcare community allows him to manage relationships with physician practices, health systems, and health plan customers effectively. This includes supporting partner onboarding and program deployment to ensure that OMI's value-based specialty care initiatives are executed with consistency across various platforms.
Dr. Andrew Pecora, Chairman and CEO of OMI, emphasized the significance of Dr. Windham’s leadership as the company looks to expand. “Chris brings deep clinical expertise and a proven ability to build strong provider and customer partnerships,” he stated. “As we scale OMI, his leadership will be critical to delivering consistent execution and supporting our continued growth.”
The Impact of Dr. Windham's Appointment
OMI's vision of delivering high-quality specialty care via real-time decision support technology stands to gain immensely from Dr. Windham’s expertise. His appointment symbolizes OMI's commitment to investing in leadership that can navigate the complexities of the healthcare landscape, ultimately driving positive business results and improved patient outcomes. It is a clear indication that OMI is gearing up for its next phase of growth, solidifying its place in the healthcare industry as a leader in specialty care.
Founded in 2018, OMI focuses on providing specialty physicians with cutting-edge decision support tools and innovative reimbursement models. The company's commitment to clinical quality outcomes while significantly reducing costs has made it a significant player among healthcare providers. Through Dr. Windham's leadership, OMI plans to enhance its clinical pathways further, aimed at conditions that carry high variability in care costs.
In summary, the arrival of Dr. Christopher Windham heralds a new chapter for OMI, one that is poised to foster innovation, efficiency, and excellence in specialty healthcare delivery.
About Outcomes Matter Innovations
Outcomes Matter Innovations, LLC (OMI) is based in New Jersey and focuses on providing real-time decision support technology for specialty care. With a goal to maintain or improve clinical quality outcomes while significantly lowering costs, OMI represents a forward-thinking model in the healthcare realm. As the company continues to expand nationally, it partners with various specialty physicians to develop clinical treatment pathways designed to improve outcomes and eliminate unnecessary care variability.
For media inquiries, reach out to Alison Brown at (860) 965-9009 or via email.